Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Perioperative management of a neurosurgical patient with a meningioma and recent coronary artery stent.

Rouine-Rapp K, McDermott MW.

J Clin Anesth. 2013 May;25(3):228-31. doi: 10.1016/j.jclinane.2012.11.007. Epub 2013 Mar 22.

PMID:
23688961
2.

Perioperative management of a neurosurgical patient requiring antiplatelet therapy.

Than KD, Rohatgi P, Wilson TJ, Gregory Thompson B.

J Clin Neurosci. 2012 Sep;19(9):1316-20. doi: 10.1016/j.jocn.2011.12.018. Epub 2012 Jul 10.

PMID:
22784876
4.

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.

Savonitto S, D'Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, Klugmann S, De Servi S.

Br J Anaesth. 2010 Mar;104(3):285-91. doi: 10.1093/bja/aep373. Epub 2010 Jan 3.

PMID:
20047898
5.

Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.

Murray AT, Sederberg JH 2nd.

Semin Cardiothorac Vasc Anesth. 2011 Mar-Jun;15(1-2):40-3. doi: 10.1177/1089253211411105.

PMID:
21840879
6.

Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.

Finkel JB, Marhefka GD, Weitz HH.

Hosp Pract (1995). 2013 Feb;41(1):79-88. doi: 10.3810/hp.2013.02.1013. Review.

PMID:
23466970
7.

Coronary stent management in elective genitourinary surgery.

Gupta AD, Streiff M, Resar J, Schoenberg M.

BJU Int. 2012 Aug;110(4):480-4. doi: 10.1111/j.1464-410X.2011.10821.x. Epub 2011 Dec 22. Review.

8.
9.

Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).

Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.

Am J Cardiol. 2009 Nov 15;104(10):1357-61. doi: 10.1016/j.amjcard.2009.07.002. Epub 2009 Sep 26.

PMID:
19892050
10.

[Perioperative anti-platelet therapy management--protocol suggestion].

Edry R, Katz Y.

Harefuah. 2011 Apr;150(4):327-32, 421, 420. Hebrew.

PMID:
22164910
11.

[Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].

Komiya R, Kamintani K, Kubo E, Hattori M, Kataoka H, Iwase Y, Miyoshi H, Minami M, Kato S, Arai R, Yoshida H.

Masui. 2014 Jun;63(6):629-35. Japanese.

PMID:
24979851
12.

Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.

Mohammad RA, Goldberg T, Dorsch MP, Cheng JW.

Clin Ther. 2010 Dec;32(14):2265-81. doi: 10.1016/j.clinthera.2011.01.003. Review.

PMID:
21353100
13.

Patients with drug-eluting stents and management of their anticoagulant therapy in cutaneous surgery.

Chu MB, Turner RB, Kriegel DA.

J Am Acad Dermatol. 2011 Mar;64(3):553-8. doi: 10.1016/j.jaad.2009.11.691. Epub 2011 Jan 20. Review.

PMID:
21255871
14.

Coronary artery stents: II. Perioperative considerations and management.

Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL.

Anesth Analg. 2008 Aug;107(2):570-90. doi: 10.1213/ane.0b013e3181731e95. Review.

PMID:
18633036
15.

Bridging therapy in the perioperative management of patients with drug-eluting stents.

Chou S, Eshaghian S, Lamer A, Tran H, Dohad S, Kaul S.

Rev Cardiovasc Med. 2009 Fall;10(4):209-18.

PMID:
20065931
16.

Perioperative management of patients with drug-eluting stents.

Abualsaud AO, Eisenberg MJ.

JACC Cardiovasc Interv. 2010 Feb;3(2):131-42. doi: 10.1016/j.jcin.2009.11.017. Review.

17.

[Coronary stents, dual antiplatelet therapy and peri-operative problems].

Metzler H, Huber K, Kozek-Langenecker S, Vicenzi MN, Münch A.

Anaesthesist. 2007 Apr;56(4):401-10; quiz 411-2. Review. German.

PMID:
17396240
18.

A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.

Wenaweser P, Eshtehardi P, Abrecht L, Zwahlen M, Schmidlin K, Windecker S, Meier B, Haeberli A, Hess OM.

Thromb Haemost. 2010 Sep;104(3):554-62. doi: 10.1160/TH09-11-0765. Epub 2010 Jul 20.

PMID:
20664903
19.

Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.

Savonitto S, Caracciolo M, Cattaneo M, DE Servi S.

J Thromb Haemost. 2011 Nov;9(11):2133-42. doi: 10.1111/j.1538-7836.2011.04456.x. Review.

20.

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.

Llau JV, Ferrandis R, Sierra P, Gómez-Luque A.

Vasc Health Risk Manag. 2010 Oct 5;6:855-67. doi: 10.2147/VHRM.S7402. Review.

Supplemental Content

Support Center